search
Back to results

Lifestyle Modification and Blood Pressure Study (LIMBS)

Primary Purpose

High Blood Pressure

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Yoga exercise program
Blood pressure education/walking program
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for High Blood Pressure focused on measuring hypertension, cardiovascular disease, yoga

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subjects must be willing and able to give written informed consent.
  • Age > 18 years, but < 75 years.
  • BP criteria: Systolic Blood Pressure (SBP) of > 130, but < 160 mm Hg.
  • Willing to comply with all study-related procedures.

Exclusion Criteria:

  • Subjects who are pregnant or post partum < 3 months.
  • Subjects currently taking BP lowering medications or dietary supplements (magnesium, potassium, calcium > 1200 mg/day, fish oils, ephedra, hawthorn, forskolin, etc…).
  • Stage II HTN (SBP > 160 mmHg OR diastolic blood pressure (DBP) > 100 mmHg).
  • Non-dominant arm circumference > 50 cm.
  • BMI > 40.0 kg/m2.
  • Practicing yoga >1x/month in the previous 6 months.
  • Received/used experimental drug or device within 30 days prior to screening, or donated blood > 1 pint within 8 weeks of screening.
  • Diabetes mellitis.
  • Established cardiovascular disease.
  • Known arrhythmias or cardiac pacemakers.
  • Current users (within 30 days) of any tobacco products.
  • History of renal insufficiency (glomerular filtration rate < 60 ml/min).
  • Women consuming > 7 alcoholic drinks/week; men consuming > 14 drinks/week.
  • Known autonomic neuropathy.
  • Known secondary cause of HTN (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronism).
  • Benzodiazepine, anti-psychotic drugs (3 month stable use of SSRIs are allowed), or steroid use.
  • Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga.
  • Use of other mind/ body therapies such as Qi Gong, Tai Chi, meditation.
  • Lack Internet access.
  • Presence of non-removable metallic foreign object, surgically implanted electrical device, surgically placed metallic clip (aneurysm clip), ear implants, any history of metal implants in the eye.

Sites / Locations

  • Hospital at the University of Pennsylvania

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Experimental

Arm Label

Blood pressure education/walking program

Combined intervention

Yoga Exercise Program

Arm Description

Outcomes

Primary Outcome Measures

24-hour ambulatory blood pressure

Secondary Outcome Measures

Cerebral blood flow
Urinary Isoprostane
serum asymmetric dimethylarginine (ADMA)
salivary cortisol
psychological measures of mood, perceived stress and health competence
physiological measures of flexibility

Full Information

First Posted
August 24, 2009
Last Updated
February 13, 2017
Sponsor
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT00964847
Brief Title
Lifestyle Modification and Blood Pressure Study
Acronym
LIMBS
Official Title
Lifestyle Modification and Blood Pressure Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
August 2009 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare the effects of 24 weeks of either a blood pressure education and walking program versus a yoga exercise program versus the combined intervention of blood pressure education and yoga on reducing mild to moderate high blood pressure in pre-hypertension and stage 1 hypertension subjects.
Detailed Description
The study is a non-blinded, randomized controlled trial to assess the safety and efficacy of 24 weeks of a structured yoga exercise program (YP) versus a blood pressure education and walking program (BPEP) versus the combined intervention on reducing mild to moderate high blood pressure in adults with pre-hypertension or stage 1 hypertension. This will be done through a single center trial using a parallel design. All potential subjects will be screened first by telephone and then by 2 outpatient visits at the Clinical and Translational Research Center (CTRC) at the hospital of the University of Pennsylvania. Eligible subjects will then make 3 visits to the CTRC where they will be admitted overnight to have non-invasive 24-hour recordings of BP, as well as have periodic blood, urine and saliva collections. The entire study duration is 28 weeks (24 weeks post-randomization) and includes a total of 7 evaluation visits (including 2 functional magnetic resonance imaging visits) and a termination visit. Subjects will be randomized to YP, BPEP or the combined intervention of YP and BPEP.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High Blood Pressure
Keywords
hypertension, cardiovascular disease, yoga

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
147 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Blood pressure education/walking program
Arm Type
Active Comparator
Arm Title
Combined intervention
Arm Type
Active Comparator
Arm Title
Yoga Exercise Program
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Yoga exercise program
Other Intervention Name(s)
YP
Intervention Description
Subjects in the yoga exercise program participate in structured bi-weekly 1.5 hour yoga classes held at a yoga studio as well as develop a weekly hour-long home practice over the 6 months of the study.
Intervention Type
Behavioral
Intervention Name(s)
Blood pressure education/walking program
Other Intervention Name(s)
BPEP
Intervention Description
The program will consist of small group health education classes and a walking program. Subjects will be expected to attend a dietician-led nutrition class twice a month. On alternate weeks the subjects will be given either motivational talks about a variety of topics including weight loss, walking programs, and healthy lifestyle choices or they will be given educational DVDs or literature to read on the weeks that they are not attending a BPEP class. These subjects will all receive 12 nutrition classes and 12 motivational experiences. The subjects will also be expected to walk 6 days a week gradually increasing to 180 minutes of walking per week or 10,000 steps per day.
Primary Outcome Measure Information:
Title
24-hour ambulatory blood pressure
Time Frame
baseline, 12 weeks, 24 weeks
Secondary Outcome Measure Information:
Title
Cerebral blood flow
Time Frame
baseline, 12 weeks, 24 weeks
Title
Urinary Isoprostane
Time Frame
baseline, 12 weeks, 24 weeks
Title
serum asymmetric dimethylarginine (ADMA)
Time Frame
baseline, 12 weeks, 24 weeks
Title
salivary cortisol
Time Frame
baseline, 12 weeks, 24 weeks
Title
psychological measures of mood, perceived stress and health competence
Time Frame
baseline, 12 weeks, 24 weeks
Title
physiological measures of flexibility
Time Frame
baseline, 12 weeks, 24 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects must be willing and able to give written informed consent. Age > 18 years, but < 75 years. BP criteria: Systolic Blood Pressure (SBP) of > 130, but < 160 mm Hg. Willing to comply with all study-related procedures. Exclusion Criteria: Subjects who are pregnant or post partum < 3 months. Subjects currently taking BP lowering medications or dietary supplements (magnesium, potassium, calcium > 1200 mg/day, fish oils, ephedra, hawthorn, forskolin, etc…). Stage II HTN (SBP > 160 mmHg OR diastolic blood pressure (DBP) > 100 mmHg). Non-dominant arm circumference > 50 cm. BMI > 40.0 kg/m2. Practicing yoga >1x/month in the previous 6 months. Received/used experimental drug or device within 30 days prior to screening, or donated blood > 1 pint within 8 weeks of screening. Diabetes mellitis. Established cardiovascular disease. Known arrhythmias or cardiac pacemakers. Current users (within 30 days) of any tobacco products. History of renal insufficiency (glomerular filtration rate < 60 ml/min). Women consuming > 7 alcoholic drinks/week; men consuming > 14 drinks/week. Known autonomic neuropathy. Known secondary cause of HTN (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronism). Benzodiazepine, anti-psychotic drugs (3 month stable use of SSRIs are allowed), or steroid use. Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga. Use of other mind/ body therapies such as Qi Gong, Tai Chi, meditation. Lack Internet access. Presence of non-removable metallic foreign object, surgically implanted electrical device, surgically placed metallic clip (aneurysm clip), ear implants, any history of metal implants in the eye.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Debbie Cohen, M.D.
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital at the University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17917509
Citation
Cohen D, Townsend RR. Yoga and hypertension. J Clin Hypertens (Greenwich). 2007 Oct;9(10):800-1. doi: 10.1111/j.1751-7176.2007.tb00008.x. No abstract available.
Results Reference
background
PubMed Identifier
19769471
Citation
Cohen DL, Wintering N, Tolles V, Townsend RR, Farrar JT, Galantino ML, Newberg AB. Cerebral blood flow effects of yoga training: preliminary evaluation of 4 cases. J Altern Complement Med. 2009 Jan;15(1):9-14. doi: 10.1089/acm.2008.0008.
Results Reference
background
PubMed Identifier
19734256
Citation
Cohen DL, Bloedon LT, Rothman RL, Farrar JT, Galantino ML, Volger S, Mayor C, Szapary PO, Townsend RR. Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial. Evid Based Complement Alternat Med. 2011;2011:546428. doi: 10.1093/ecam/nep130. Epub 2011 Feb 14.
Results Reference
background
PubMed Identifier
26773737
Citation
Cohen DL, Boudhar S, Bowler A, Townsend RR. Blood Pressure Effects of Yoga, Alone or in Combination With Lifestyle Measures: Results of the Lifestyle Modification and Blood Pressure Study (LIMBS). J Clin Hypertens (Greenwich). 2016 Aug;18(8):809-16. doi: 10.1111/jch.12772. Epub 2016 Jan 15.
Results Reference
derived
PubMed Identifier
23721984
Citation
Cohen DL, Bowler A, Fisher SA, Norris A, Newberg A, Rao H, Bhavsar R, Detre JA, Tenhave T, Townsend RR. Lifestyle Modification in Blood Pressure Study II (LIMBS): study protocol of a randomized controlled trial assessing the efficacy of a 24 week structured yoga program versus lifestyle modification on blood pressure reduction. Contemp Clin Trials. 2013 Sep;36(1):32-40. doi: 10.1016/j.cct.2013.05.010. Epub 2013 May 27.
Results Reference
derived

Learn more about this trial

Lifestyle Modification and Blood Pressure Study

We'll reach out to this number within 24 hrs